{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:05:03Z","timestamp":1790096703492,"version":"4.0.1"},"reference-count":76,"publisher":"Elsevier","isbn-type":[{"value":"9780443470882","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.enz.2026.03.001","type":"book-chapter","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:37:13Z","timestamp":1776289033000},"page":"101-134","source":"Crossref","is-referenced-by-count":0,"title":["Matrix metalloproteinase-13 selective inhibitors"],"prefix":"10.1016","author":[{"given":"Simone","family":"Giovannuzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.enz.2026.03.001_bib0001","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/cr9804543","article-title":"Design and therapeutic application of matrix metalloproteinase inhibitors","volume":"99","author":"Whittaker","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/bs.enz.2026.03.001_bib0002","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/0929867013373417","article-title":"The design, structure, and therapeutic application of matrix metalloproteinase inhibitors","volume":"8","author":"Skiles","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0003","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2174\/0929867043364018","article-title":"The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors","volume":"11","author":"Skiles","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0004","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2174\/092986708784567680","article-title":"Progress in the development of matrix metalloproteinase inhibitors","volume":"15","author":"Tu","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jcp.21535","article-title":"Role of the hemopexin domain of matrix metalloproteinases in cell migration","volume":"217","author":"Dufour","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/bs.enz.2026.03.001_bib0006","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/cells9051076","article-title":"Structure and function of human matrix metalloproteinases","volume":"9","author":"Laronha","year":"2020","journal-title":"Cells"},{"key":"10.1016\/bs.enz.2026.03.001_bib0007","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2174\/092986708785747490","article-title":"Structural bases for substrate and inhibitor recognition by matrix metalloproteinases","volume":"15","author":"Aureli","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0008","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1385\/MB:25:3:241","article-title":"Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases","volume":"25","author":"Maskos","year":"2003","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/bs.enz.2026.03.001_bib0009","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/0929867053363243","article-title":"Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results","volume":"12","author":"Kontogiorgis","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0010","doi-asserted-by":"crossref","first-page":"51646","DOI":"10.1074\/jbc.M310109200","article-title":"The intermediate S1\u2032 pocket of the endometase\/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling","volume":"278","author":"Park","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0011","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/6657","article-title":"Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors","volume":"6","author":"Lovejoy","year":"1999","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/bs.enz.2026.03.001_bib0012","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1074\/jbc.271.3.1544","article-title":"Biochemical characterization of human collagenase-3","volume":"271","author":"Kn\u00e4uper","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0013","doi-asserted-by":"crossref","first-page":"24091","DOI":"10.1074\/jbc.M114.583443","article-title":"The recognition of collagen and triple-helical toolkit peptides by MMP-13: sequence specificity for binding and cleavage","volume":"289","author":"Howes","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0014","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/ijms22041742","article-title":"Overview of MMP-13 as a promising target for the treatment of osteoarthritis","volume":"22","author":"Hu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2026.03.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116786","article-title":"The role of matrix metalloproteinases in osteoarthritis pathogenesis: an updated review","volume":"234","author":"Mehana","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/bs.enz.2026.03.001_bib0016","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s13075-017-1454-2","article-title":"New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis","volume":"19","author":"Li","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/bs.enz.2026.03.001_bib0017","first-page":"590","article-title":"Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis","volume":"23","author":"Wernicke","year":"1996","journal-title":"J. Rheumatol."},{"key":"10.1016\/bs.enz.2026.03.001_bib0018","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/1529-0131(200003)43:3<664::AID-ANR24>3.0.CO;2-D","article-title":"Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase","volume":"43","author":"Billinghurst","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/bs.enz.2026.03.001_bib0019","first-page":"499","article-title":"Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck","volume":"151","author":"Johansson","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/bs.enz.2026.03.001_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/1523-1747.ep12319441","article-title":"Human collagenase-3 is expressed in malignant squamous epithelium of the skin","volume":"109","author":"Airola","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/bs.enz.2026.03.001_bib0021","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/med.20204","article-title":"Selective MMP13 inhibitors","volume":"31","author":"Li","year":"2011","journal-title":"Med. Res. Rev."},{"key":"10.1016\/bs.enz.2026.03.001_bib0022","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cup.13603","article-title":"Matrix metalloproteinases MMP-1, MMP-2, and MMP-13 are overexpressed in primary nodular melanoma","volume":"47","author":"Zamolo","year":"2020","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/bs.enz.2026.03.001_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41523-023-00513-6","article-title":"TGF\u03b2-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression","volume":"9","author":"Gibson","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/bs.enz.2026.03.001_bib0024","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1158\/0008-5472.CAN-20-2705","article-title":"Host-derived matrix metalloproteinase-13 activity promotes multiple myeloma-induced osteolysis and reduces overall survival","volume":"81","author":"Lo","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/bs.enz.2026.03.001_bib0025","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3892\/ijmm.2017.2885","article-title":"Resveratrol inhibits the IL-1 -induced expression ofMMP-13 and IL-6 in human articular chondrocytes viaTLR4\/MyD88-dependent and-independent signaling cascades","volume":"39","author":"Gu","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/bs.enz.2026.03.001_bib0026","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000345345","article-title":"Inhibition effect of curcumin on TNF- and MMP-13 expression induced by advanced glycation end products in chondrocytes","volume":"91","author":"Yang","year":"2013","journal-title":"Pharmacology"},{"key":"10.1016\/bs.enz.2026.03.001_bib0027","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/ar2700","article-title":"Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor- and matrix metalloproteinase-13 in human chondrocytes","volume":"11","author":"Rasheed","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/bs.enz.2026.03.001_bib0028","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tips.2022.03.014","article-title":"3D cell cultures toward quantitative high-throughput drug screening","volume":"43","author":"Wang","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/bs.enz.2026.03.001_bib0029","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3390\/ijms22041676","article-title":"Advances in de novo drug design: from conventional to machine learning methods","volume":"22","author":"Mouchlis","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2026.03.001_bib0030","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1038\/s41467-024-47613-w","article-title":"Prospective de novo drug design with deep interactome learning","volume":"15","author":"Atz","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.enz.2026.03.001_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012494","article-title":"Cheminformatics-based drug design approach for identification of inhibitors targeting the characteristic residues of MMP-13 hemopexin domain","volume":"5","author":"Kothapalli","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/bs.enz.2026.03.001_bib0032","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/1568026615666150813150631","article-title":"Non-zinc-binding inhibitors of MMP-13: GRID-based approaches to rationalize the binding process","volume":"16","author":"Di Pizio","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0033","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1016\/S0960-894X(00)00584-9","article-title":"Synthesis and activity of selective MMP inhibitors with an aryl backbone","volume":"10","author":"Barta","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.03.001_bib0034","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0960-894X(01)00487-5","article-title":"Selective, orally active MMP inhibitors with an aryl backbone","volume":"11","author":"Barta","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.03.001_bib0035","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/S0960-894X(01)00556-X","article-title":"alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1","volume":"11","author":"Becker","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.03.001_bib0036","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/S0960-894X(01)00557-1","article-title":"alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1","volume":"11","author":"Becker","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.03.001_bib0037","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1021\/jm0500875","article-title":"Synthesis and structure-activity relationships of beta- and alpha-piperidine sulfone hydroxamic acid matrix metalloproteinase inhibitors with oral antitumor efficacy","volume":"48","author":"Becker","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0038","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1021\/jm100669j","article-title":"Orally active MMP-1 sparing \u03b1-tetrahydropyranyl and \u03b1-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease","volume":"53","author":"Becker","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0039","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1016\/j.bmcl.2010.04.111","article-title":"MMP-13 selective isonipecotamide alpha-sulfone hydroxamates","volume":"20","author":"Kolodziej","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.03.001_bib0040","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1016\/j.bmcl.2011.03.099","article-title":"MMP-13 selective \u03b1-sulfone hydroxamates: a survey of P1\u2032 heterocyclic amide isosteres","volume":"21","author":"Barta","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.03.001_bib0041","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1016\/j.bmcl.2011.08.087","article-title":"Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13","volume":"21","author":"Tommasi","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.03.001_bib0042","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.bcp.2012.06.026","article-title":"N-O-isopropyl sulfonamido-based hydroxamates: kinetic characterisation of a series of MMP-12\/MMP-13 dual target inhibitors","volume":"84","author":"Santamaria","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/bs.enz.2026.03.001_bib0043","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1021\/jm801394m","article-title":"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13","volume":"52","author":"Monovich","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0044","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/acs.jmedchem.6b01007","article-title":"Discovery of novel, highly potent, and selective matrix metalloproteinase (MMP)-13 inhibitors with a 1,2,4-triazol-3-yl moiety as a zinc binding group using a structure-based design approach","volume":"60","author":"Nara","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0045","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1016\/j.bmcl.2013.05.089","article-title":"Hydantoin based inhibitors of MMP13\u2014discovery of AZD6605","volume":"23","author":"De Savi","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.03.001_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129014","article-title":"Development of a putative Zn\u00b2\u207a-chelating but highly selective MMP-13 inhibitor","volume":"76","author":"Fuerst","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.03.001_bib0047","doi-asserted-by":"crossref","first-page":"27781","DOI":"10.1074\/jbc.M703286200","article-title":"Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects","volume":"282","author":"Johnson","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0048","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/art.24629","article-title":"A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models","volume":"60","author":"Baragi","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/bs.enz.2026.03.001_bib0049","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.bmcl.2009.11.081","article-title":"Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis","volume":"20","author":"Schnute","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.03.001_bib0050","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/art.27596","volume":"62","author":"Settle","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/bs.enz.2026.03.001_bib0051","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1021\/acs.jmedchem.5b01434","volume":"59","author":"Ruminski","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0052","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bioorg.2010.11.002","article-title":"Heteroarylimino-4-thiazolidinones as inhibitors of cartilage degradation","volume":"39","author":"Panico","year":"2011","journal-title":"Bioorg. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0053","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/cmdc.201100223","article-title":"Benzisothiazolyliminothiazolidin-4-ones with chondroprotective properties: searching for potent and selective inhibitors of MMP-13","volume":"6","author":"Vicini","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/bs.enz.2026.03.001_bib0054","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1016\/j.bmcl.2011.05.075","article-title":"Selective non zinc binding inhibitors of MMP13","volume":"21","author":"De Savi","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.03.001_bib0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bmcl.2011.11.034","article-title":"Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2","volume":"22","author":"De Savi","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.03.001_bib0056","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejmech.2011.10.035","article-title":"Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization","volume":"47","author":"La Pietra","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0057","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.1016\/j.bmcl.2011.09.077","article-title":"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds","volume":"21","author":"Roth","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.03.001_bib0058","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1021\/acs.jmedchem.7b00514","article-title":"Structure-based design and synthesis of potent and selective matrix metalloproteinase 13 inhibitors","volume":"60","author":"Choi","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0059","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1021\/jm201152u","article-title":"Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis","volume":"55","author":"Gege","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029615","article-title":"An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer","volume":"7","author":"Shah","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.enz.2026.03.001_bib0061","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1021\/jm500981k","article-title":"Discovery of novel, highly potent, and selective quinazoline-2-carboxamide-based matrix metalloproteinase (MMP)-13 inhibitors without a zinc binding group using a structure-based design approach","volume":"57","author":"Nara","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0062","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1016\/j.bmc.2014.07.025","article-title":"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1\u2033 binding site","volume":"22","author":"Nara","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0063","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3109\/14756366.2014.1000889","article-title":"Kinetic characterization of 4,4\u2032-biphenylsulfonamides as selective non-zinc binding MMP inhibitors","volume":"30","author":"Santamaria","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0064","doi-asserted-by":"crossref","first-page":"9585","DOI":"10.1021\/acs.jmedchem.7b01001","article-title":"Targeted polypharmacology: discovery of a highly potent non-hydroxamate dual matrix metalloproteinase (MMP)-10\/-13 inhibitor","volume":"60","author":"Senn","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103616","article-title":"Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10\/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology","volume":"96","author":"El Ashry","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106839","article-title":"Battling colorectal cancer via s-triazine-based MMP-10\/13 inhibitors armed with electrophilic warheads for concomitant ferroptosis induction, the first-in-class dual-acting agents","volume":"141","author":"Morcos","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0067","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2423174","article-title":"Structure optimization and molecular dynamics studies of new tumor-selective s-triazines targeting DNA and MMP-10\/13 for halting colorectal and secondary liver cancers","volume":"39","author":"Morcos","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0068","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1080\/09168451.2016.1200456","article-title":"Functional characterization of selective exosite-binding inhibitors of matrix metalloproteinase-13 (MMP-13)\u2014experimental validation in human breast and colon cancer","volume":"80","author":"Kothapalli","year":"2016","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0069","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/acs.jmedchem.6b01284","article-title":"Radiolabeled selective matrix metalloproteinase 13 (MMP-13) inhibitors: (Radio)syntheses and in vitro and first in vivo evaluation","volume":"60","author":"Hugenberg","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0070","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1021\/acs.jmedchem.2c02107","article-title":"Quinazoline-2-carboxamides as selective PET radiotracers for matrix metalloproteinase-13 imaging in atherosclerosis","volume":"66","author":"Buchler","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113666","article-title":"Development of a selective matrix metalloproteinase 13 (MMP-13) inhibitor for the treatment of osteoarthritis","volume":"224","author":"Bendele","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.03.001_bib0072","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311098","article-title":"Identification of N-acyl hydrazones as new non-zinc-binding MMP-13 inhibitors by structure-based virtual screening studies and chemical optimization","volume":"24","author":"Cuffaro","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2026.03.001_bib0073","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1039\/D3TB02871B","article-title":"On-demand release of a selective MMP-13 blocker from an enzyme-responsive injectable hydrogel protects cartilage from degenerative progression in osteoarthritis","volume":"12","author":"Roy","year":"2024","journal-title":"J. Mater. Chem. B."},{"key":"10.1016\/bs.enz.2026.03.001_bib0074","doi-asserted-by":"crossref","first-page":"8877","DOI":"10.1021\/bi301228d","article-title":"Development of a neutralizing antibody specific for the active form of matrix metalloproteinase-13","volume":"51","author":"Naito","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/bs.enz.2026.03.001_bib0075","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1517\/13543776.2013.779254","article-title":"New selective inhibitors of MMP-13 for inflammatory diseases: a patent evaluation (W02012151158)","volume":"23","author":"Li","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/bs.enz.2026.03.001_bib0076","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/13543776.2023.2284935","article-title":"An updated patent review of matrix metalloproteinase (MMP) inhibitors (2021-present)","volume":"33","author":"Banerjee","year":"2023","journal-title":"Expert Opin. Ther. Pat."}],"container-title":["The Enzymes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604726000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604726000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:08:59Z","timestamp":1790093339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874604726000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443470882"],"references-count":76,"URL":"https:\/\/doi.org\/10.1016\/bs.enz.2026.03.001","relation":{},"ISSN":["1874-6047"],"issn-type":[{"value":"1874-6047","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}